Quantitative proteomic analysis of HIV‐1 Tat‐induced dysregulation in SH‐SY5Y neuroblastoma cells. Issue 6 (27th February 2017)

• Record Type: Journal Article
• Authors: Ganief, Tariq; Gqamana, Putuma; Garnett, Shaun; Hoare, Jackie; Stein, Dan J.; Joska, John; Soares, Nelson; Blackburn, Jonathan M.
• Other Names: Pandey Akhilesh guestEditor.
• Is Part Of: Proteomics. Volume 17:Issue 6(2017)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2017-02-27
• Subjects: Cytoskeleton -- HIV dementia -- Neurodegeneration -- Pathway analysis -- SILAC; Proteins -- Separation -- Periodicals; Bioinformatics -- Periodicals; Proteomics -- Periodicals; Genomes -- Periodicals; Molecular genetics -- Periodicals; 572.605
• DOI: 10.1002/pmic.201600236
• Languages: English
• ISSNs: 1615-9853

Abstract

Abstract : Despite affecting up to 70% of HIV‐positive patients and being the leading cause of dementia in patients under 40 years, the molecular mechanisms involved in the onset of HIV‐associated neurocognitive disorders (HAND) are not well understood. To address this, we performed SILAC‐based quantitative proteomic analysis on HIV‐Tat treated SH‐SY5Y neuroblastoma cells. Isolated protein was fractionated by SDS‐PAGE and analyzed by nLC‐MS/MS on an Orbitrap Velos. Using MaxQuant, we identified and quantified 3077 unique protein groups, of which 407 were differentially regulated. After applying an additional standard deviation‐based cutoff, 29 of these were identified as highly significantly and stably dysregulated. GO term analysis shows dysregulation in both protein translation machinery as well as cytoskeletal regulation that have both been implicated in other dementias. In addition, several key cytoskeletal regulatory proteins such as ARHGEF17, the Rho GTPase, SHROOM3, and CMRP1 are downregulated. Together, these data demonstrate that HIV‐Tat can dysregulate neuronal cytoskeletal regulatory proteins that could lead to the major HAND clinical manifestation‐synapse loss.